ATS receives a US $3.

This client has once again shown its confidence in ATS by awarding us this important high profile project in another of their essential operating divisions.’ Mr. Woerner added that ATS is usually ‘well positioned to address the challenges connected with high volume manufacture of several new drug delivery products. In addition to our full selection of automation capabilities, these applications can reap the benefits of our substantial knowledge in several specialized fields, including eyesight inspection, aseptic assembly and processing to enable efficient and reliable produce of a range of drug delivery devices.’.. ATS receives a US $3.8 million order for a manufacturing system for new medication delivery technology ATS Automation Tooling Systems Inc.has announced it has received a US $3.8 million order from one of the world’s largest pharmaceutical companies to provide a production system for a fresh medication delivery technology.Having mined the literature to amass 2,516 potential biomarkers of pancreatic cancer, On April 6 in PLoS Medicine Pandey and his team are publishing their compendium. They systematically cataloged the proteins and genes that are overexpressed in pancreatic cancer patients, after that compared and characterized these biomarker candidates in terms of how worthy each is of further study. More than 200 genes are shortlisted because they were reported in four or even more published studies to be overexpressed – – and therefore the proteins they make are in higher abundance in people who have pancreatic cancer than in people without the condition. This qualifies them as ‘excellent applicants’ for the further research that are had a need to validate them as sensitive and specific biomarkers, take note the authors.